{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-24-008068","form_type":"8-K","ticker":null,"cik":"0001617765","company_name":"EVOME MEDICAL TECHNOLOGIES INC.","filed_at":"2024-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.268852+00:00","generated_at":"2026-06-04T02:19:34.034420+00:00","sec_items":["1.01","2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Evome sells Simbex R&D unit to Riddell for $3.55M cash; proceeds cut acquisition debt","bullets":["Sale price $3.55M (~$4.83M CAD) cash for Simbex LLC to EB Sports Corp (Riddell parent).","Proceeds reduce Simbex senior debt by ~$824k and Biodex acquisition debt by ~$2.12M.","Annual revenue to decline ~$6M but net income impact immaterial; balance sheet strengthened.","CEO notes two consecutive quarters of positive Adjusted EBITDA; expects 'breakout' Q2 for Biodex.","New products: RST (Reactive Step Trainer) launched Feb 2024; SpaceTek Knee planned late 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-24-008068","json":"https://secwatch.observer/filing/0001062993-24-008068.json","markdown":"https://secwatch.observer/filing/0001062993-24-008068.md","text":"https://secwatch.observer/filing/0001062993-24-008068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324008068/0001062993-24-008068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324008068/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:19:34.034420+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"90ca2d5dabc409d491ad1b3f7085edcd37c212f0","claim":"EVOME MEDICAL TECHNOLOGIES INC. completed a disposition involving EB Sports Corp. for $3,550,000 (closed 2024-04-01).","evidence_excerpt":"the Purchaser agreed to purchase from the Seller all of the issued and outstanding membership interests owned by the Seller in Simbex LLC, a Delaware limited liability company (the \" Membership Interests \") for a purchase price of $3,550,000","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324008068/0001062993-24-008068-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"EB Sports Corp."},{"label":"Consideration","value":"$3,550,000"},{"label":"Closing","value":"2024-04-01"}],"fact_type":"ma_transaction"},{"claim_id":"58b3dafe599569ce18f9d25acc7e6aebe6d739db","claim":"EVOME MEDICAL TECHNOLOGIES INC. entered into Purchase Agreement with EB Sports Corp. valued at $3,550,000 (effective 2024-04-01).","evidence_excerpt":"On April 1, 2024, Evome Medical Technologies Inc., a British Columbia corporation (the \" Company \"), its wholly-owned subsidiary Simbex Acquisition I Corporation, a Delaware corporation (\" Seller \"), and EB Sports Corp., a Delaware corporation (the \" Purchaser \"), entered into a membership interest purchase agreement (the \" Purchase Agreement \"), pursuant to which the Purchaser agreed to purchase from the Seller all of the issued and outstanding membership interests owned by the Seller in Simbex LLC, a Delaware limited liability company (the \" Membership Interests \") for a purchase price of $3,550,000, subject to certain adjustments for working capital, indebtedness, and transaction expenses.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324008068/0001062993-24-008068-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"EB Sports Corp."},{"label":"Value","value":"$3,550,000"},{"label":"Effective","value":"2024-04-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}